Cyclo Therapeutics Inc [CYTH] stock is trading at $0.69, up 6.15%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CYTH shares have gain 16.95% over the last week, with a monthly amount glided 13.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cyclo Therapeutics Inc [CYTH] stock has fluctuated between $0.55 and $2.12 over the past year. Currently, Wall Street analysts expect the stock to reach $0.95 within the next 12 months. Cyclo Therapeutics Inc [NASDAQ: CYTH] shares were valued at $0.69 at the most recent close of the market. An investor can expect a potential return of 37.68% based on the average CYTH price forecast.
Analyzing the CYTH fundamentals
Cyclo Therapeutics Inc [NASDAQ:CYTH] reported sales of 0.87M for the trailing twelve months, which represents a drop of -52.82%. Gross Profit Margin for this corporation currently stands at -2.06% with Operating Profit Margin at -28.34%, Pretax Profit Margin comes in at -28.48%, and Net Profit Margin reading is -28.48%. To continue investigating profitability, this company’s Return on Assets is posted at -4.72, Equity is 7.5 and Total Capital is 1.83. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6669 points at the first support level, and at 0.6439 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7165, and for the 2nd resistance point, it is at 0.7431.
Ratios To Look Out For
For context, Cyclo Therapeutics Inc’s Current Ratio is 0.17. As well, the Quick Ratio is 0.16, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 22.69.
